Patent · US Active

Sustained-release nanoparticle compositions and methods using the same

US9138416B2 · kind B2 · utility

3Cited by
3References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2013
Grant dateSep 22, 2015
Priority date
Expiry dateOct 28, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/906
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is a composition composed of a therapeutic agent encapsulated in a copolymer of an N-alkylacrylamide, a vinyl monomer, and a polyethylene glycol (PEG) conjugate and a method for using the same in the treatment or prevention of a disease or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.